THE WHAT Global investment group Eurazeo has announced the majority stake purchase of Beekman 1802.
THE DETAILS Clean beauty brand Beekman 1802 has a range of prestige skin and body care products made from microbiome science and contain goat’s milk.
Eurazeo is investing US$62 million out of a total of US$92 million to acquire a majority stake alongside co-investors Cohesive Capital Partners and the Cherng Family Trust.
As part of Eurazeo’s investment, Marc Rey, former CEO of Shiseido Americas, will join the Company’s Board of Directors as Chairman, alongside Adrianne Shapira, Managing Director, and George Birman, Principal at Eurazeo.
THE WHY Eurazeo’s financial investment will help Beekman 1802 expand across multiple channels, categories, and geographies.
Brent Ridge and Josh Kilmer-Purcell, Beekman 1802 co-founders, said, “When we started Beekman 1802 over a decade ago, we were focused on helping our community; over the years we have been fortunate to grow that community near and far through our unique products that are kind to sensitive skin and our use of Kindness as a framework for wellness and well-being. Today we couldn’t be more excited to embark on Beekman’s next journey together with Eurazeo, a partner with strong brand building expertise that will help us grow our community of neighbors and spread kindness globally.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
